Country: Аустралија
Језик: Енглески
Извор: APVMA (Australian Pesticides and Veterinary Medicines Authority)
CANINE ADENO VIRUS TYPE 2; CANINE DISTEMPER VIRUS - LIVING; CANINE PARVO VIRUS TYPE 2
ZOETIS AUSTRALIA PTY LTD
canine distemper virus+canine adenovirus+canine parvovirus
MISC. VACCINES OR ANTI SERA
CANINE ADENO VIRUS TYPE 2 VACCINE-VIRAL Active 0.0 U; CANINE DISTEMPER VIRUS - LIVING VACCINE-VIRAL Active 0.0 U; CANINE PARVO VIRUS TYPE 2 VACCINE-VIRAL Active 0.0 U
100 x 1mL; 20 x 1mL; 25 x 1mL; 80 x 1mL
VM - Veterinary Medicine
ZOETIS AUSTRALIA
DOG | BITCH | CASTRATE | PUPPY
IMMUNOTHERAPY
CANINE DISTEMPER | CANINE PARVOVIRUS | HEPATITIS :- INFECTIOUS | CANINE ADENOVIRUS TYPE 1 | CANINE ADENOVIRUS TYPE 2 | INFECTIOUS CANINE HEPATITIS | PARVOVIRUS
Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: DOG: [CANINE DISTEMPER, CANINE PARVOVIRUS, HEPATITIS :- INFECTIOUS]; Poison schedule: 4; Withholding period: ; Host/pest details: DOG: [CANINE DISTEMPER, CANINE PARVOVIRUS, HEPATITIS :- INFECTIOUS]; For the protection of dogs against canine distemper, infectious canine hepatitis, canine parvovirus and respiratory disease caused by canine adenovirus type 2 - provides cross-protection against CPV-2, CPV-2a & CPV-2b virus subtypes.Not to be used in pregnant bitches or in puppies less than 6 weeks of age. Dogs should not be vaccinated when they are: incubating an infectious disease; seriously debilitated by another infectious disease, parasitic infestation or malnutrition; or under
Registered
2023-07-01
COMPANY NAME: PRODUCT NAME: APVMA APPROVAL NO: ZOETIS AUSTRALIA PTY LTD CANVAC 3 VACCINE 52773/101885 LABEL NAME: CANVAC 3 VACCINE SIGNAL HEADINGS: PRESCRIPTION ANIMAL REMEDY KEEP OUT OF REACH OF CHILDREN FOR ANIMAL TREATMENT ONLY CONSTITUENT STATEMENTS: CANVAC 3 vaccine contains living attenuated distemper virus ≥ 10 7.0 TCID50/L, living attenuated canine adenovirus type 2 (CAV-2) ≥ 10 6.5 TCID50/L and living attenuated canine parvovirus type 2 (CPV-2) ≥ 10 8.1 TCID50/L. All three viruses are produced in continuous cell lines and freeze-dried. Each batch conforms to accepted standards for safety, potency, purity and freedom from abnormal toxicity. CLAIMS: For the protection of dogs against canine distemper, infectious canine hepatitis, canine parvovirus and respiratory disease caused by canine adenovirus type 2. Canvac 3 provides cross-protection against CPV-2, CPV-2a, and CPV-2b virus subtypes. NET CONTENTS: 100 x 1mL 20 x 1mL 80 x 1mL DIRECTIONS FOR USE: READ THE ENCLOSED LEAFLET BEFORE USING THIS PRODUCT RESTRAINTS: CONTRAINDICATIONS: This product should not be used in pregnant bitches or in puppies less than 6 weeks of age. Dogs should not be vaccinated when they are: 1. incubating an infectious disease; 2. seriously debilitated by another infectious disease, parasitic infestation or malnutrition; or 3. under treatment with immunosuppressive drugs. PRECAUTIONS: Successful immunisation depends on an adequate amount of viable virus being present in the reconstituted vaccine at the time of injection. This can be ensured only if the vaccine is stored at the stipulated temperature. The vaccine may be reconstituted in the diluent at room temperature. RLP APPROVED Care should be taken not to contaminate the needle or vial during reconstitution and injection. The vaccine must not be exposed to, or contaminated by, alcohols or other disinfectants as this could inactivate the living virus. SIDE EFFECTS: Systemic allergic reactions such as anaphylaxis are thought to occur rarely with all vaccines and may require Прочитајте комплетан документ
PRODUCT NAME: CANVAC® 3 VACCINE PAGE: 1 OF 4 This revision issued: October, 2015 MATERIAL SAFETY DATA SHEET Issued by: Zoetis Australia Pty Ltd Phone: 1800 814 883 POISONS INFORMATION CENTRE: 13 1126 FROM ANYWHERE IN AUSTRALIA, (0800 764 766 IN NEW ZEALAND) SECTION 1 - IDENTIFICATION OF THE MATERIAL AND SUPPLIER ZOETIS AUSTRALIA PTY LTD ABN 94 156 476 425 Level 6, 5 Rider Blvd Rhodes NSW 2138 AUSTRALIA Tel: 1800 814 883 Fax: (02) 8876 0444 Email: australia.animalhealth@zoetis.com CHEMICAL NATURE: Freeze dried virus plus other stabilising ingredients. TRADE NAME: CANVAC ® 3 VACCINE OTHER NAME: COMBINED CANINE DISTEMPER, INFECTIOUS HEPATITIS AND PARVOVIRUS VACCINE, LIVING PRODUCT USE: When reconstituted, for the immunisation of dogs against canine distemper, infectious hepatitis and parvovirus. Administered by injection. CREATION DATE: MAY, 2004 THIS VERSION ISSUED: OCTOBER, 2015 and is valid until August, 2016. SECTION 2 - HAZARDS IDENTIFICATION STATEMENT OF HAZARDOUS NATURE This product is classified as: Not classified as hazardous according to the criteria of SWA Australia. Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code. RISK PHRASES: Not Hazardous - No criteria found. SAFETY PHRASES: Not Hazardous - No criteria found. SUSMP CLASSIFICATION: S4 (Aust), S2 (NZ) ADG CLASSIFICATION: None allocated. Not a Dangerous Good. UN NUMBER: None allocated E E E M M M E E E R R R G G G E E E N N N C C C Y Y Y O O O V V V E E E R R R V V V I I I E E E W W W PHYSICAL DESCRIPTION & COLOUR : Vial with pale fawn coloured freeze dried pellet ODOUR: No data - expected to be mild. MAJOR HEALTH HAZARDS: no significant risk factors have been found for this product. P P P O O O T T T E E E N N N T T T I I I A A A L L L H H H E E E A A A L L L T T T H H H E E E F F F F F F E E E C C C T T T S S S THE ACTIVE VIRUSES ARE INFECTIOUS TO ANIMALS ONLY. INHALATION SHORT TERM EXPOSURE: Significant inhalation exposure is considered to be unlikely. Long term inhalation of high amounts of any nuisance dust may overload Прочитајте комплетан документ